跳至主要内容
临床试验/IRCT2012101911168N1
IRCT2012101911168N1已完成未知

The antioxidant effect of quercetin supplementation on the glycemic control, lipid profile and oxidative stress in type 2 diabetic patients.

Shiraz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 60 years(—)
性别
All

入选标准

  • age range 35-60 years; having controlled diabetes (no need for changes in oral hypoglycemic medication during the study or having HbA1C <7%, pre-prandial capillary blood glucose <150 mg/dl and peak postprandial capillary blood glucose <180 mg/dl); maximum period of 10 years from the diagnosis of the disease; having normal blood pressure (systolic and diastolic blood pressure: <120 mmHg and <80 mmHg, respectively).
  • Exclusion criteria: smoking and/or drinking alcohol; having documented liver/kidney and/or lung diseases, kidney stone or any other type of chronic and/or acute inflammatory disorder; taking any lipid lowering and/or hypotensive medication and multi-vitamin mineral supplements; having documented clinically significant secondary complication of the disease (i.e. diabetic retinopathy, nephropathy and neuropathy)

排除标准

  • 未提供

研究者

相似试验